Skip to main content
Pure Biologics S.A. logo

Pure Biologics S.A. — Investor Relations & Filings

Ticker · PUR ISIN · PLPRBLG00010 LEI · 2594002TXS19AUYHIF82 WAR Manufacturing
Open in API
Filings indexed 515 across all filing types
Latest filing 2026-03-04 Share Issue/Capital Cha…
Country PL Poland
Listing WAR PUR

About Pure Biologics S.A.

https://purebiologics.com/

Pure Biologics S.A. is a biopharmaceutical company engaged in the discovery and development of novel biological drugs and non-systemic therapies. The company leverages its expertise in antibody and aptamer technologies to create innovative treatments. Its therapeutic portfolio is primarily focused on immuno-oncology. A key aspect of its strategy is the development of original, non-generic and non-biosimilar, biological drug candidates.

Recent filings

Filing Released Lang Actions
Dopuszczenie i warunkowe wprowadzenie do obrotu na rynku równoległym prowadzonym przez GPW akcji serii P2 oraz serii I Spółki. Ustalenie daty pierwszego notowania akcji serii P2 oraz serii I Spółki...
Share Issue/Capital Change Classification · 95% confidence The document is a regulatory announcement from Pure Biologics S.A. regarding the admission and introduction of new shares (Series I and P2) to trading on the Warsaw Stock Exchange (GPW). This relates to a change in the company's capital structure and share issuance. According to the provided definitions, announcements regarding new share issues or capital changes fall under the 'SHA' category.
2026-03-04 Polish
Treść Zawiadomienia ACRX Investment Limited
Major Shareholding Notification Classification · 100% confidence The document is a formal notification ('Zawiadomienie') submitted by a shareholder (ACRX Investments Limited) regarding changes in their significant shareholding in a company (Pure Biologics S.A.). It references Article 69 of the Polish Act on Public Offering, which is the standard regulatory requirement for disclosing changes in major shareholdings (crossing thresholds). This fits the definition of a Major Shareholding Notification.
2026-02-20 Polish
Zawiadomienie akcjonariusza o zmianie stanu posiadania akcji Spółki - Content (PL)
Major Shareholding Notification Classification · 100% confidence The document is a notification from Pure Biologics S.A. regarding a change in shareholding status by a major shareholder (ACRX Investments Limited). This type of disclosure, specifically referencing Article 69 of the Polish Act on Public Offering, is a standard regulatory requirement for reporting significant changes in share ownership levels. It fits the definition of a Major Shareholding Notification.
2026-02-20 Polish
Terminy przekazywania raportów okresowych w 2026 r. - Content (PL)
Report Publication Announcement Classification · 100% confidence The document is a short announcement from Pure Biologics S.A. detailing the specific calendar dates for the publication of future periodic reports (quarterly, semi-annual, and annual) for the year 2026. It does not contain the actual financial data or the reports themselves, but rather serves as a notification of the reporting schedule. According to the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2026-01-30 Polish
Rejestracja akcji na okaziciela serii P2 w depozycie papierów wartościowych prowadzonym przez KDPW - Content (PL)
Share Issue/Capital Change Classification · 95% confidence The document is a short announcement from Pure Biologics S.A. regarding the registration of new shares (series P2) with the Central Securities Depository of Poland (KDPW). It details the specific number of shares and the effective date of registration. This falls under the category of share issuance or capital changes.
2026-01-27 Polish
Asymilacja akcji serii P1 Spółki z akcjami Spółki znajdującymi się w obrocie na rynku równoległym - Content (PL)
Share Issue/Capital Change Classification · 95% confidence The document is a regulatory announcement from Pure Biologics S.A. regarding the assimilation of shares (series P1) by the Central Securities Depository of Poland (KDPW). It details the technical process of merging share codes and the subsequent admission of these shares to trading on the stock exchange. This falls under capital changes and share issuance/admission procedures, which is best classified as a share issue/capital change announcement.
2026-01-21 Polish

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.